
Analysts Viewpoint
Nautilus Biotechnology Inc’s latest rating changes from various analysts
Nautilus Biotechnology Inc’s recently made public that its CFO and Treasurer Mowry Anna acquired Company’s shares for reported $11488.0 on
Nautilus Biotechnology Inc’s recently made public that its CFO and Treasurer Mowry Anna acquired Company’s shares for reported $11488.0 on
In a filing, Nautilus Biotechnology Inc revealed its CFO and Treasurer Mowry Anna acquired Company’s shares for reported $11488.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nautilus Biotechnology
Nautilus Biotechnology Inc’s recent filing unveils that its CFO and Treasurer Mowry Anna acquired Company’s shares for reported $11488.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nautilus Biotechnology